Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphoma.
Ghez D, Fortpied C, Mounier N, Carde P, Perrot A, Khaled H, Amorim S, Ramadan S, Bras FL, Erlanson M, Herbaux C, Marolleau JP, Nicolas-Virelezier E, Casasnovas O, Stamatoullas-Bastard A, Fermé C. Ghez D, et al. Among authors: ramadan s. Bone Marrow Transplant. 2017 Feb;52(2):310-312. doi: 10.1038/bmt.2016.271. Epub 2016 Nov 28. Bone Marrow Transplant. 2017. PMID: 27892946 Clinical Trial. No abstract available.
Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.
Maraldo MV, Giusti F, Vogelius IR, Lundemann M, van der Kaaij MA, Ramadan S, Meulemans B, Henry-Amar M, Aleman BM, Raemaekers J, Meijnders P, Moser EC, Kluin-Nelemans HC, Feugier P, Casasnovas O, Fortpied C, Specht L; European Organisation for Research and Treatment of Cancer (EORTC) Lymphoma Group. Maraldo MV, et al. Among authors: ramadan s. Lancet Haematol. 2015 Nov;2(11):e492-502. doi: 10.1016/S2352-3026(15)00153-2. Epub 2015 Oct 22. Lancet Haematol. 2015. PMID: 26686259
Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma.
Derenzini E, Tabanelli V, Sammassimo S, Mazzara S, Motta G, Melle F, Vanazzi A, Calleri A, Fiori S, Finazzi MC, Barbanti MC, Ramadan S, Gandini S, Pastano R, Rambaldi A, Pileri S, Tarella C. Derenzini E, et al. Among authors: ramadan s. Bone Marrow Transplant. 2021 Sep;56(9):2280-2283. doi: 10.1038/s41409-021-01320-y. Epub 2021 May 7. Bone Marrow Transplant. 2021. PMID: 33963303 No abstract available.
Gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive transitional and squamous cell carcinoma of the bladder: effect on survival and bladder preservation.
Khaled HM, Shafik HE, Zabhloul MS, Ghoneim M, Saber RA, Manie M, Enein HA, Megeed HA, Mansur O, Sherbini ME, Mahran TZ, Kalawee ME, Badran A, Ramadan SM. Khaled HM, et al. Among authors: ramadan sm. Clin Genitourin Cancer. 2014 Oct;12(5):e233-40. doi: 10.1016/j.clgc.2014.04.002. Epub 2014 May 6. Clin Genitourin Cancer. 2014. PMID: 24889794 Clinical Trial.
Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial.
Selleslag D, Suciu S, Meloni G, Muus P, Halkes CJ, Venditti A, Ramadan SM, Pruijt H, Meert L, Vignetti M, Marie JP, Wittnebel S, de Witte T, Amadori S, Willemze R, Baron F. Selleslag D, et al. Among authors: ramadan sm. Haematologica. 2017 Feb;102(2):e47-e51. doi: 10.3324/haematol.2016.153130. Epub 2016 Oct 27. Haematologica. 2017. PMID: 27789677 Free PMC article. Clinical Trial. No abstract available.
Clinical presentation and staging of Hodgkin lymphoma.
Gallamini A, Hutchings M, Ramadan S. Gallamini A, et al. Among authors: ramadan s. Semin Hematol. 2016 Jul;53(3):148-54. doi: 10.1053/j.seminhematol.2016.05.005. Epub 2016 May 13. Semin Hematol. 2016. PMID: 27496305 Review.
Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia.
Todisco E, Gigli F, Sammassimo S, Camisaschi C, Mancuso P, Ronchini C, Ramadan S, Bertolini F, Pastano R, Tarella C. Todisco E, et al. Among authors: ramadan s. Leuk Lymphoma. 2020 Sep;61(9):2277-2279. doi: 10.1080/10428194.2020.1759049. Epub 2020 May 2. Leuk Lymphoma. 2020. PMID: 32363964 No abstract available.
400 results